NLRP3 and asthma: Richard et al. reported that the NLRP3 inflammasome is related to the progression of severe steroid-resistant asthma, and direct therapy for the NLRP3 inflammasome could have therapeutic potency [36], which suggests the possibility that steroid therapy alone could not regulate the NLRP3 inflammasome perfectly.